TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit
· prnewswire.com · popularity 21/100 · 0 similar stories today · Law & Legal Practice (Law, Crime & Justice)
Read the original at prnewswire.com →
Summary
NEW YORK, Nov. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023 and August 7, 2026, both dates inclusive (the "Class Period"), of the important December 28,...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.